至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase.

Biochim Biophys Acta.. 2017-06; 
Gibier JB,Hémon B,Fanchon M,Gaudelot K,Pottier N,Ringot B,Van Seuningen I,Glowacki F,Cauffiez C,Blum D,Copin MC,Perrais M,Gnemmi V.
Products/Services Used Details Operation
Peptide Synthesis ... assay [19]. HEK-293 cells were treated with 5 μM GO-203 (GenScript), which blocks MUC1 peptide dimerization, or with the control peptide CP2 (GenScript), as previously described in [20]. 2.2. Animals. Animal experiments … Get A Quote

摘要

Acute kidney injury (AKI) is characterized by acute tubular necrosis (ATN) which involves mainly proximal tubules. Past AKI is associated with higher risk of chronic kidney disease (CKD). The MUC1 mucin is a large glycoprotein responsible for epithelial protection and locates to convoluted distal tubules and collecting ducts. Since MUC1 activates the epithelial-mesenchymal transition (EMT) in carcinoma cells, we hypothesized that MUC1 could be involved in epithelial tubular cell plasticity, a process that not only accompanies epithelial repair, but also participates into kidney fibrosis, histological substratum of CKD. In cultured human proximal cells and in human kidney allograft biopsies, we observed MUC1 ind... More

关键词

Acute kidney injury; Epithelial-mesenchymal transition; Fibrosis; Ischemia-reperfusion; MUC1